ARTICLE
12 April 2011

N Is For Novel Foods

CC
CMS Cameron McKenna Nabarro Olswang

Contributor

CMS is a Future Facing firm with 79 offices in over 40 countries and more than 5,000 lawyers globally. Combining local market insight with a global perspective, CMS provides business-focused advice to help clients navigate change confidently. The firm's expertise and innovative approach anticipate challenges and develop solutions. CMS is committed to diversity, inclusivity, and corporate social responsibility, fostering a supportive culture. The firm addresses key client concerns like efficiency and regulatory challenges through services like Law-Now, offering real-time eAlerts, mobile access, an extensive legal archive, specialist zones, and global events.

Novel foods are foods and food ingredients that have not been used for human consumption to a significant degree within the Community before 15 May 1997.
United Kingdom Food, Drugs, Healthcare, Life Sciences

Novel foods are foods and food ingredients that have not been used for human consumption to a significant degree within the Community before 15 May 1997.  Regulation EC 258/97 lays out detailed rules for the authorisation of novel foods and novel food ingredients.

For over 3 years, negotiations have been ongoing to revise this Regulation to take into account the latest developments on a number of important issues; including:

  • legal definition of nano-materials and their mandatory labelling,
  • a centralised and quicker authorisation procedure to facilitate innovation from the food industry and
  • specific measures for traditional foods from third countries.

However, proposals to revise the Novel Food Regulation last month failed due to disagreement on the production and commercialisation of food products from cloned animals.  The EU Parliament argued that the Novel Food Regulation should not cover food from cloned animals (or their offspring), but a special law should be adopted on it.  The Commission took the view that there are no scientific reasons to ban foodstuffs from cloned animals. According to the European Food Safety Authority (EFSA), there is no evidence that meat or milk from cloned animals poses a public health risk.  There was no clear majority between the Member States.

As cloning is an expensive process, meat from cloned animals has not been generally commercially viable to date.  However, there is commercial interest in animal husbandry from cloned animals.  Whilst there is a voluntary moratorium in the trade in meat from cloned animals in the United States this does not extend to the offspring of cloned animals and therefore traceability may become an issue.  

Now the conciliation period has ended without agreement it is not clear what form the process of revision of the 1997 Regulation will take. Uncertainty will therefore remain over the definition of nanomaterials and products originating from the offspring of cloned animals, there is also frustration at the current lengthy authorisation process for novel foods and traditional foods from non-EU countries.

Europe needs to provide industry with clarity as innovation races ahead of legislation, or else research and development may be restricted.

This article was written for Law-Now, CMS Cameron McKenna's free online information service. To register for Law-Now, please go to www.law-now.com/law-now/mondaq

Law-Now information is for general purposes and guidance only. The information and opinions expressed in all Law-Now articles are not necessarily comprehensive and do not purport to give professional or legal advice. All Law-Now information relates to circumstances prevailing at the date of its original publication and may not have been updated to reflect subsequent developments.

The original publication date for this article was 08/04/2011.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More